- World rank, all time
- #25,266 of 42,892
- Rank in ??
- #429 of 1,041
- Research works
- 132 ▲ 160% vs 2013–17
- Citations
- 3.9k 29.4 per fractional work
- Top-10% rate
- 27.3% record average 16.5%
- Open access
- 50% world 28%
What does Ospedale di Macerata specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.3× the share of its output that it takes of world research.
- MedicineField · 28.2 works4.3×
- Health SciencesDomain · 28.5 works3.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.
- Medicine 4.3×
- Immunology and Microbiology 3.1×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Neuroscience 0.3×
- Environmental Science 0.2×
- Health Professions 0.2×
- Nursing 0.2×
- Mathematics 0.1×
- Psychology 0.1×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.0×
- Social Sciences 0.0×
Who are the top researchers at Ospedale di Macerata?
Ranked on the composite score, Salomone Di Saverio, Federico Coccolini and Fausto Catena lead among researchers whose main affiliation is Ospedale di Macerata.
- 1 Salomone Di Saverio ?? · #5,237 worldwide 806 citations · 67 works
- 2 Federico Coccolini ?? · #9,564 worldwide 665 citations · 58 works
- 3 Fausto Catena ?? · #17,588 worldwide 579 citations · 43 works
- 4 Massimo Sartelli ?? · #24,400 worldwide 526 citations · 38 works
Which keywords describe research at Ospedale di Macerata?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Guidelines, Treatment, Epidemiology, Diagnosis, Molecular Characterization, Genetic Mutations and Complications.
- Diverticulitis
- Urothelial Carcinoma
- Bladder Cancer
- Sepsis
- Mortality
- Gene Expression
- PD-1 and PD-L1
- Cancer
- Renal Cell Carcinoma
- Meta-Analysis
- Metastatic
- Surgery
- Therapy
- Neoadjuvant Therapy
- Management
- Prognostic Factors
- Genetic Mutations
- Molecular Characterization
- Treatment
- Immunotherapy
- Epidemiology
- Guidelines
- Diagnosis
- Complications
- Clinical Guidelines
- Children
- Tumor Microenvironment
- Antibiotic Therapy
- Chemotherapy
- Biomarkers
- CT Scan
- Nephron-Sparing Surgery
- Appendicitis
- Immune Checkpoint Blockade
- Targeted Therapy
- Healthcare-Associated Infections
- Surgical Management
- Antibiotic Resistance
- Postoperative Complications
- Colonic Diverticulitis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 3.7×23 topics
- Immunotherapy5▲ 19×11 topics
- Guidelines4▲ 27×7 topics
- Treatment4▲ 10×10 topics
- Diagnosis3▲ 10×11 topics
- Molecular Characterization3▲ 52×2 topics
- Complications3▲ 18×8 topics
- Genetic Mutations3▲ 21×5 topics
- Clinical Guidelines3▲ 30×4 topics
- Prognostic Factors3▲ 19×5 topics
- Children3▲ 33×3 topics
- Management3▲ 10×8 topics
- Tumor Microenvironment3▲ 18×5 topics
- Neoadjuvant Therapy2▲ 31×5 topics
- Antibiotic Therapy2▲ 115×2 topics
- Therapy2▲ 32×3 topics
- Chemotherapy2▲ 8.8×11 topics
- Surgery2▲ 17×5 topics
- Biomarkers2▲ 8.5×6 topics
- Metastatic2▲ 92×2 topics
- CT Scan2▲ 54×2 topics
- Meta-Analysis2▲ 9.5×4 topics
- Nephron-Sparing Surgery2▲ 166×1 topic
- Renal Cell Carcinoma2▲ 166×1 topic
- Appendicitis2▲ 185×1 topic
- Cancer2▲ 3.6×12 topics
- Immune Checkpoint Blockade2▲ 46×1 topic
- PD-1 and PD-L12▲ 46×1 topic
- Targeted Therapy2▲ 20×4 topics
- Gene Expression1▲ 6.6×6 topics
- Healthcare-Associated Infections1▲ 34×3 topics
- Mortality1▲ 7.1×7 topics
- Surgical Management1▲ 9.9×7 topics
- Sepsis1▲ 23×3 topics
- Antibiotic Resistance1▲ 8.9×3 topics
- Bladder Cancer1▲ 97×1 topic
- Postoperative Complications1▲ 26×2 topics
- Urothelial Carcinoma1▲ 84×1 topic
- Colonic Diverticulitis1▲ 162×1 topic
- Diverticulitis1▲ 162×1 topic
Which research topics does Ospedale di Macerata publish most on?
By volume in 2022–2025: Renal cell carcinoma treatment, Appendicitis Diagnosis and Management, Cancer Immunotherapy and Biomarkers and Bladder and Urothelial Cancer Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 2 works
- 2 Appendicitis Diagnosis and Management Emergency Medicine 2 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 4 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 5 Diverticular Disease and Complications Surgery 1 works
- 6 Cancer Genomics and Diagnostics Cancer Research 1 works
- 7 Gastrointestinal disorders and treatments Surgery 1 works
- 8 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 1 works
- 9 Abdominal Surgery and Complications Pulmonary and Respiratory Medicine 1 works
- 10 Surgical site infection prevention Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ospedale di Macerata's research output changed?
Output in 2018–2022 was 160% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.